Review of beta blocker myocardial infarction trials.
This is a brief review of the current state of knowledge of beta adrenergic-blocking agents in the treatment of acute myocardial infarction. Their effects when administered in the acute phase of infarction, and in special subgroups of patients who have sustained an acute infarction, are discussed. Particular emphasis is directed to their effect on arrhythmias and in patients with left ventricular dysfunction. In addition, data are presented which suggest the advantage of permanent therapy of beta blockers in patients who have sustained a myocardial infarction and in whom the drug is tolerated.